TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
CRDF

Cardiff Oncology Inc

Healthcare · Biotechnology

1.10$ +2.2% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Cardiff Oncology Inc (CRDF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 37 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRDF
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
53 44 34 13 12 12 10 22 18 14 15 14 12 13 12 30 39 135 130 144 141 150 139 131 124 116 107 97 88 82 74 66 63 97 85 76 64 62 49 37
48 39 30 8.7 8.6 9.5 7.8 20 16 13 12 12 10.0 11 10 29 38 133 129 143 138 146 136 127 120 111 102 93 84 77 70 62 59 95 83 74 62 60 47 36
23 38 10 7.8 7.4 8.2 6.7 18 15 11 11 11 9.0 10 9.3 28 36 131 15 11 13 12 20 21 19 16 15 19 15 22 19 26 13 51 24 11 10 17 8.5 9.2
47 38 29 7.8 7.4 8.2 6.7 19 15 11 11 11 9.0 10 9.3 28 36 131 126 140 134 141 129 122 114 105 97 89 81 75 67 60 58 92 80 71 61 58 46 35
0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.3 0.2 0.3 0.4 0.5 0.4 0.6 0.7 0.8 0.7 0.2 0.2 0.3 0.4 0.5 0.6 0.8 0.4 0.5 0.3 0.2 0.2 0.2
0.0 – – 0.0 0.0 0.0 – – – – – 0.0 0.0 0.0 – – – – 0.0 – – – – – 0.0 – – 0.0 – – 0.0 – – – – – – – – –
– 3.8 3.6 3.3 3.1 2.4 2.2 1.8 1.6 1.3 0.3 0.3 0.3 0.9 0.8 1.2 1.1 0.6 0.5 0.6 0.4 0.4 3.2 1.1 1.3 1.3 1.3 1.4 – – – – – – – – – – – –
26 24 23 9.0 8.3 5.8 5.7 4.3 3.9 4.1 4.8 5.0 5.3 5.8 5.7 5.7 5.9 6.6 4.8 4.8 7.8 9.1 9.1 11 10 9.8 10 11 11 12 13 14 14 14 14 17 15 16 14 11
6.6 7.8 9.0 7.5 5.1 3.9 3.9 3.2 2.7 3.0 3.3 3.7 4.2 4.8 4.9 5.0 5.4 6.1 4.5 4.6 5.0 6.6 6.7 8.5 8.2 7.8 8.1 9.1 9.0 10 12 13 13 13 13 17 15 16 14 11
0.8 2.4 3.9 1.6 1.5 1.3 1.2 – – – 0.8 0.8 0.8 0.9 0.9 0.9 1.2 0.9 0.6 0.4 0.6 0.6 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.6 0.5
0.9 1.1 1.0 0.6 0.7 0.8 0.7 0.6 0.5 0.7 0.5 0.5 0.5 0.7 0.6 1.2 0.6 1.4 0.8 0.5 0.4 1.4 1.3 1.5 1.4 2.0 2.9 2.9 2.2 2.0 5.2 5.1 4.6 4.8 3.6 6.0 2.4 8.1 5.5 4.0
– – – – – – – – – – – – – – – 0.2 – – – – – – – – – – – – – – – – – – – – – – – –
27 20 11 3.5 3.9 6.5 4.7 17 14 10 9.7 8.8 6.7 7.3 6.1 24 34 128 125 139 134 140 130 120 113 106 97 87 78 70 61 52 49 83 71 59 49 45 35 27
-140 -148 -158 -166 -170 -173 -178 -184 -188 -192 -196 -201 -205 -209 -213 -220 -225 -231 -237 -243 -250 -260 -271 -281 -290 -298 -309 -320 -330 -340 -349 -361 -372 -384 -398 -412 -423 -430 -442 -452
0.4 0.4 0.4 0.4 0.5 0.6 0.8 1.2 3.4 3.8 4.1 5.4 6.0 8.3 9.9 14 23 23 37 39 40 41 43 43 43 45 45 45 45 45 45 45 47 48 48 67 67 67 68 68

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?